217 related articles for article (PubMed ID: 23016931)
1. Nitric oxide-mediated regulation of β-amyloid clearance via alterations of MMP-9/TIMP-1.
Ridnour LA; Dhanapal S; Hoos M; Wilson J; Lee J; Cheng RY; Brueggemann EE; Hines HB; Wilcock DM; Vitek MP; Wink DA; Colton CA
J Neurochem; 2012 Dec; 123(5):736-49. PubMed ID: 23016931
[TBL] [Abstract][Full Text] [Related]
2. Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro.
Liao MC; Van Nostrand WE
Biochemistry; 2010 Feb; 49(6):1127-36. PubMed ID: 20050683
[TBL] [Abstract][Full Text] [Related]
3. The MMP-2/TIMP-2 System in Alzheimer Disease.
Wang H; Huang L; Wu L; Lan J; Feng X; Li P; Peng Y
CNS Neurol Disord Drug Targets; 2020; 19(6):402-416. PubMed ID: 32787764
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ.
Yan P; Hu X; Song H; Yin K; Bateman RJ; Cirrito JR; Xiao Q; Hsu FF; Turk JW; Xu J; Hsu CY; Holtzman DM; Lee JM
J Biol Chem; 2006 Aug; 281(34):24566-74. PubMed ID: 16787929
[TBL] [Abstract][Full Text] [Related]
5. Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by beta-amyloid 25-35 fragment.
Hernández-Guillamon M; Delgado P; Ortega L; Pares M; Rosell A; García-Bonilla L; Fernández-Cadenas I; Borrell-Pagès M; Boada M; Montaner J
J Neurosci Res; 2009 Jul; 87(9):2115-25. PubMed ID: 19235898
[TBL] [Abstract][Full Text] [Related]
6. Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9.
Hernandez-Guillamon M; Mawhirt S; Blais S; Montaner J; Neubert TA; Rostagno A; Ghiso J
J Biol Chem; 2015 Jun; 290(24):15078-91. PubMed ID: 25897080
[TBL] [Abstract][Full Text] [Related]
7. Regulation of matrix metalloproteinase 2 by oligomeric amyloid β protein.
Li W; Poteet E; Xie L; Liu R; Wen Y; Yang SH
Brain Res; 2011 Apr; 1387():141-8. PubMed ID: 21376707
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
[TBL] [Abstract][Full Text] [Related]
9. Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease.
Portelius E; Zhang B; Gustavsson MK; Brinkmalm G; Westman-Brinkmalm A; Zetterberg H; Lee VM; Trojanowski JQ; Blennow K
Neurodegener Dis; 2009; 6(5-6):258-62. PubMed ID: 19955704
[TBL] [Abstract][Full Text] [Related]
10. Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2.
Wilcock DM; Lewis MR; Van Nostrand WE; Davis J; Previti ML; Gharkholonarehe N; Vitek MP; Colton CA
J Neurosci; 2008 Feb; 28(7):1537-45. PubMed ID: 18272675
[TBL] [Abstract][Full Text] [Related]
11. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
[TBL] [Abstract][Full Text] [Related]
12. Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease.
Paris D; Ganey NJ; Laporte V; Patel NS; Beaulieu-Abdelahad D; Bachmeier C; March A; Ait-Ghezala G; Mullan MJ
J Neuroinflammation; 2010 Mar; 7():17. PubMed ID: 20211007
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
Fragkouli A; Tsilibary EC; Tzinia AK
Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
[TBL] [Abstract][Full Text] [Related]
14. Regulation of MMP/TIMP by HUVEC transplantation attenuates ventricular remodeling in response to myocardial infarction.
Kwon JS; Kim YS; Cho AS; Cho HH; Kim JS; Hong MH; Jeong HY; Kang WS; Hwang KK; Bae JW; Jeong MH; Cho MC; Ahn Y
Life Sci; 2014 Apr; 101(1-2):15-26. PubMed ID: 24560960
[TBL] [Abstract][Full Text] [Related]
15. The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells.
Lee EO; Kang JL; Chong YH
J Biol Chem; 2005 Mar; 280(9):7845-53. PubMed ID: 15632190
[TBL] [Abstract][Full Text] [Related]
16. Nitroglycerin alters matrix remodeling proteins in THP-1 human macrophages and plasma metalloproteinase activity in rats.
Krishnatry AS; Fung SM; Brazeau DA; Soda D; Fung HL
Nitric Oxide; 2011 Mar; 24(2):66-76. PubMed ID: 21156214
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-β increases metallo- and cysteine protease activities in human macrophages.
Castellano J; Badimon L; Llorente-Cortés V
J Vasc Res; 2014; 51(1):58-67. PubMed ID: 24335416
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism.
Yin KJ; Cirrito JR; Yan P; Hu X; Xiao Q; Pan X; Bateman R; Song H; Hsu FF; Turk J; Xu J; Hsu CY; Mills JC; Holtzman DM; Lee JM
J Neurosci; 2006 Oct; 26(43):10939-48. PubMed ID: 17065436
[TBL] [Abstract][Full Text] [Related]
19. Expression profile of matrix metalloproteinase-2 and -9 and their endogenous tissue inhibitors in osteonecrotic femoral heads.
Grässel S; Beckmann J; Rath B; Vogel M; Grifka J; Tingart M
Int J Mol Med; 2010 Jul; 26(1):127-33. PubMed ID: 20514432
[TBL] [Abstract][Full Text] [Related]
20. rd1 mouse retina shows imbalance in cellular distribution and levels of TIMP-1/MMP-9, TIMP-2/MMP-2 and sulfated glycosaminoglycans.
Ahuja S; Ahuja P; Caffé AR; Ekstrom P; Abrahamson M; van Veen T
Ophthalmic Res; 2006; 38(3):125-36. PubMed ID: 16374054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
